Breadcrumb

CIM News

Immunotherapy showing significant advancements in lung cancer treatment

Phase 3 clinical trial of neoadjuvant nivolumab leads to practice-changing results

TB and COVID-19, a joint battle?

On World TB Day 2022, we are looking at how researchers from the McGill International TB Centre at the RI-MUHC are working to raise awareness and to put an end to TB.

What’s the signature of a healthy heart?

Instead of treating the “average person,” the Courtois Cardiovascular Signature Program aims to treat every person as a unique individual

Raquel del Carpio-O’Donovan elected Honorary President by the World Federation of Neuroradiological Societies

World-class neuroradiologist regards her career as “an enormous fortune”

Three renewed Canada Research Chairs for RI-MUHC researchers

Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs

$2M to the MUHC Foundation for precision cancer care

BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program

RI-MUHC research team leads new consortium to make healthcare data more accessible

The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...

Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States

Recruitment of first U.S.-based patients in dapsone trial has started

RI-MUHC team studies a novel, fully automated insulin delivery system

A new publication in Lancet Digital Health describes an important step that may improve glucose control and quality of life for people with type 1...

Explore news and events at the RI-MUHC